# Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms

> **NCT01990339** · — · COMPLETED · sponsor: **Takeda** · enrollment: 14965 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease With Dyspepsia Symptoms

## Interventions

- **DRUG:** Lansoprazole

## Key facts

- **NCT ID:** NCT01990339
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 14965 (ACTUAL)
- **Last updated:** 2016-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01990339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01990339, "Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01990339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*